We have a deep understanding of how to evaluate your condition and how select and combine treatments to get the best possible results — even for rare cancers that many doctors in the community never ...

The latest approval allows Calquence use with bendamustine and rituximab for adults with newly diagnosed mantle cell lymphoma who are not eligible to undergo hematopoietic stem cell transplantation.